Oral lactoferrin administration does not impact the diversity or composition of the infant gut microbiota in a Peruvian cohort

ABSTRACT Lactoferrin is a protein from breast milk involved in early-life microbiome assembly. It is believed to promote the growth of lactic acid-producing bacteria and inhibit pathogens by limiting iron availability and enabling an acidic environment in the gut. Previous reports suggest that oral...

Full description

Bibliographic Details
Main Authors: Luis González, Jose Luis Paredes Sosa, Susan Mosquito, Yesenia Filio, Pedro E. Romero, Theresa J. Ochoa, Pablo Tsukayama
Format: Article
Language:English
Published: American Society for Microbiology 2023-12-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.00096-23
_version_ 1827586724867342336
author Luis González
Jose Luis Paredes Sosa
Susan Mosquito
Yesenia Filio
Pedro E. Romero
Theresa J. Ochoa
Pablo Tsukayama
author_facet Luis González
Jose Luis Paredes Sosa
Susan Mosquito
Yesenia Filio
Pedro E. Romero
Theresa J. Ochoa
Pablo Tsukayama
author_sort Luis González
collection DOAJ
description ABSTRACT Lactoferrin is a protein from breast milk involved in early-life microbiome assembly. It is believed to promote the growth of lactic acid-producing bacteria and inhibit pathogens by limiting iron availability and enabling an acidic environment in the gut. Previous reports suggest that oral administration of lactoferrin in neonates promotes the increase of gut microbiota diversity and the enrichment of beneficial microbes. However, its effect on infant gut microbiota over time has yet to be thoroughly studied to fully understand its potential as a prebiotic. Using 16s rRNA gene amplicon sequencing, we analyzed the gut microbiota composition of 60 toddlers at 12–18 months of age from Lima, Peru, who received daily oral administration of lactoferrin or placebo for 6 months since enrollment. Samples were analyzed at 0, 2, and 4 months after beginning treatment. Our results show that lactoferrin treatment does not increase gut microbiota diversity over time nor affect its bacterial composition compared to the placebo group. IMPORTANCE Previous studies have suggested that oral lactoferrin enhances diversity in the gut microbiota in infants while inhibiting the growth of opportunistic pathogens. However, the effect of lactoferrin on infant gut microbiota over time has yet to be thoroughly studied. Our study suggests that lactoferrin oral treatment in infants aged 12–18 months does not affect gut microbiome diversity and composition over time. To our knowledge, this is the first study to report the effect of lactoferrin on infant gut microbiome composition over time and helps elucidate its impact on infant health and its therapeutic potential.
first_indexed 2024-03-09T00:05:54Z
format Article
id doaj.art-1ec1294fb5f74bd78f11a6970cd8bc8a
institution Directory Open Access Journal
issn 2165-0497
language English
last_indexed 2024-03-09T00:05:54Z
publishDate 2023-12-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj.art-1ec1294fb5f74bd78f11a6970cd8bc8a2023-12-12T13:17:19ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972023-12-0111610.1128/spectrum.00096-23Oral lactoferrin administration does not impact the diversity or composition of the infant gut microbiota in a Peruvian cohortLuis González0Jose Luis Paredes Sosa1Susan Mosquito2Yesenia Filio3Pedro E. Romero4Theresa J. Ochoa5Pablo Tsukayama6Laboratorio de Genómica Microbiana, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia , Lima, PeruLaboratorio de Genómica Microbiana, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia , Lima, PeruLaboratorio de Genómica Microbiana, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia , Lima, PeruLaboratorio de Genómica Microbiana, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia , Lima, PeruFacultad de Ciencias Biológicas, Universidad Nacional Mayor de San Marcos , Lima, PeruInstituto de Medicina Tropical Alexander von Humboldt , Lima, PeruLaboratorio de Genómica Microbiana, Facultad de Ciencias e Ingeniería, Universidad Peruana Cayetano Heredia , Lima, PeruABSTRACT Lactoferrin is a protein from breast milk involved in early-life microbiome assembly. It is believed to promote the growth of lactic acid-producing bacteria and inhibit pathogens by limiting iron availability and enabling an acidic environment in the gut. Previous reports suggest that oral administration of lactoferrin in neonates promotes the increase of gut microbiota diversity and the enrichment of beneficial microbes. However, its effect on infant gut microbiota over time has yet to be thoroughly studied to fully understand its potential as a prebiotic. Using 16s rRNA gene amplicon sequencing, we analyzed the gut microbiota composition of 60 toddlers at 12–18 months of age from Lima, Peru, who received daily oral administration of lactoferrin or placebo for 6 months since enrollment. Samples were analyzed at 0, 2, and 4 months after beginning treatment. Our results show that lactoferrin treatment does not increase gut microbiota diversity over time nor affect its bacterial composition compared to the placebo group. IMPORTANCE Previous studies have suggested that oral lactoferrin enhances diversity in the gut microbiota in infants while inhibiting the growth of opportunistic pathogens. However, the effect of lactoferrin on infant gut microbiota over time has yet to be thoroughly studied. Our study suggests that lactoferrin oral treatment in infants aged 12–18 months does not affect gut microbiome diversity and composition over time. To our knowledge, this is the first study to report the effect of lactoferrin on infant gut microbiome composition over time and helps elucidate its impact on infant health and its therapeutic potential.https://journals.asm.org/doi/10.1128/spectrum.00096-23lactoferrinearly life microbiome16S rRNA sequencingPerugut microbiota
spellingShingle Luis González
Jose Luis Paredes Sosa
Susan Mosquito
Yesenia Filio
Pedro E. Romero
Theresa J. Ochoa
Pablo Tsukayama
Oral lactoferrin administration does not impact the diversity or composition of the infant gut microbiota in a Peruvian cohort
Microbiology Spectrum
lactoferrin
early life microbiome
16S rRNA sequencing
Peru
gut microbiota
title Oral lactoferrin administration does not impact the diversity or composition of the infant gut microbiota in a Peruvian cohort
title_full Oral lactoferrin administration does not impact the diversity or composition of the infant gut microbiota in a Peruvian cohort
title_fullStr Oral lactoferrin administration does not impact the diversity or composition of the infant gut microbiota in a Peruvian cohort
title_full_unstemmed Oral lactoferrin administration does not impact the diversity or composition of the infant gut microbiota in a Peruvian cohort
title_short Oral lactoferrin administration does not impact the diversity or composition of the infant gut microbiota in a Peruvian cohort
title_sort oral lactoferrin administration does not impact the diversity or composition of the infant gut microbiota in a peruvian cohort
topic lactoferrin
early life microbiome
16S rRNA sequencing
Peru
gut microbiota
url https://journals.asm.org/doi/10.1128/spectrum.00096-23
work_keys_str_mv AT luisgonzalez orallactoferrinadministrationdoesnotimpactthediversityorcompositionoftheinfantgutmicrobiotainaperuviancohort
AT joseluisparedessosa orallactoferrinadministrationdoesnotimpactthediversityorcompositionoftheinfantgutmicrobiotainaperuviancohort
AT susanmosquito orallactoferrinadministrationdoesnotimpactthediversityorcompositionoftheinfantgutmicrobiotainaperuviancohort
AT yeseniafilio orallactoferrinadministrationdoesnotimpactthediversityorcompositionoftheinfantgutmicrobiotainaperuviancohort
AT pedroeromero orallactoferrinadministrationdoesnotimpactthediversityorcompositionoftheinfantgutmicrobiotainaperuviancohort
AT theresajochoa orallactoferrinadministrationdoesnotimpactthediversityorcompositionoftheinfantgutmicrobiotainaperuviancohort
AT pablotsukayama orallactoferrinadministrationdoesnotimpactthediversityorcompositionoftheinfantgutmicrobiotainaperuviancohort